Blar i NTNU Open på forfatter "Jamtøy, Kent Are"
-
Botulinum toxin injections towards Sphenopalatine ganglion for orofacial and headache conditions: Safety and efficacy
Jamtøy, Kent Are (Doctoral theses at NTNU;2024:429, Doctoral thesis, 2024)This dissertation is based on two clinical studies and one retrospective study. The first study was a non-randomized pilot study involving patients with chronic rhinosinusitis with nasal polyposis (CRSwNP) and the second ... -
Measurement and implications of the distance between the sphenopalatine ganglion and nasal mucosa: a neuroimaging study
Crespi, Joan Vidal; Bratbak, Daniel Fossum; Dodick, David W.; Matharu, Manjit; Jamtøy, Kent Are; Aschehoug, Irina; Tronvik, Erling Andreas (Journal article; Peer reviewed, 2018)Background Historical reports describe the sphenopalatine ganglion (SPG) as positioned directly under the nasal mucosa. This is the basis for the topical intranasal administration of local anaesthetic (LA) towards the ... -
Onabotulinum toxin A block of the sphenopalatine ganglion in patients with persistent idiopathic facial pain: a randomized, triple-blind, placebo-controlled, exploratory, cross-over study
Jamtøy, Kent Are; Thorstensen, Wenche Moe; Stovner, Lars Jacob; Rosén, Annika; Maarbjerg, Stine; Bratbak, Daniel Fossum; Simpson, Melanie Rae; Tronvik, Erling Andreas (Peer reviewed; Journal article, 2023)Objective To investigate the efficacy and safety of injecting onabotulinum toxin A (BTA) towards the sphenopalatine ganglion (SPG) using the MultiGuide® in patients with persistent idiopathic facial pain (PIFP). Methods This ... -
OnabotulinumtoxinA injection towards the SPG for treating symptoms of refractory chronic rhinosinusitis with nasal polyposis: a pilot study
Jamtøy, Kent Are; Tronvik, Erling Andreas; Bratbak, Daniel Fossum; Crespi, Joan Vidal; Stovner, Lars Jacob; Aschehoug, Irina; Thorstensen, Wenche Moe (Peer reviewed; Journal article, 2021)Background and objective The main objective of this prospective, open, uncontrolled pilot study was to investigate the safety of administering onabotulinumtoxinA (BTA) towards the sphenopalatine ganglion (SPG) in 10 patients ...